Silverman R - Search Results

1

Performance-based financing at the Global Fund to Fight AIDS, Tuberculosis and Malaria: an analysis of grant ratings and funding, 2003-12.

Fan VY, Duran D, Silverman R, Glassman A. Fan VY, et al. Among authors: silverman r. Lancet Glob Health. 2013 Sep;1(3):e161-8. doi: 10.1016/S2214-109X(13)70017-2. Epub 2013 Aug 23. Lancet Glob Health. 2013. PMID: 25104264 Free article.

2

How a new funding model will shift allocations from the Global Fund to Fight AIDS, tuberculosis, and malaria.

Fan VY, Glassman A, Silverman RL. Fan VY, et al. Health Aff (Millwood). 2014 Dec;33(12):2238-46. doi: 10.1377/hlthaff.2014.0240. Epub 2014 Nov 12. Health Aff (Millwood). 2014. PMID: 25392001

3

On results reporting and evidentiary standards: spotlight on the Global Fund.

Friebel R, Silverman R, Glassman A, Chalkidou K. Friebel R, et al. Among authors: silverman r. Lancet. 2019 May 11;393(10184):2006-2008. doi: 10.1016/S0140-6736(18)33055-1. Epub 2019 Jan 25. Lancet. 2019. PMID: 30691700 No abstract available.

4

The Global Fund impact - Authors' reply.

Friebel R, Silverman R, Glassman A, Chalkidou K. Friebel R, et al. Among authors: silverman r. Lancet. 2019 Nov 9;394(10210):1709. doi: 10.1016/S0140-6736(19)32628-5. Lancet. 2019. PMID: 31709994 No abstract available.

5

Does HIV/AIDS funding undermine health systems?

Fan VY, Silverman R, Glassman A. Fan VY, et al. Among authors: silverman r. Am J Trop Med Hyg. 2012 Sep;87(3):579-580. doi: 10.4269/ajtmh.2012.12-0291a. Am J Trop Med Hyg. 2012. PMID: 22956718 Free PMC article. No abstract available.

6

The efficacy of interventions to reduce adolescent childbearing in low- and middle-income countries: a systematic review.

McQueston K, Silverman R, Glassman A. McQueston K, et al. Among authors: silverman r. Stud Fam Plann. 2013 Dec;44(4):369-88. doi: 10.1111/j.1728-4465.2013.00365.x. Stud Fam Plann. 2013. PMID: 24323658 Review.

7

How to Get Cost-Effectiveness Analysis Right? The Case of Vaccine Economics in Latin America.

Glassman A, Cañón O, Silverman R. Glassman A, et al. Among authors: silverman r. Value Health. 2016 Dec;19(8):913-920. doi: 10.1016/j.jval.2016.04.014. Value Health. 2016. PMID: 27987640 Free PMC article.

8

Market-driven, value-based, advance commitment (MVAC): accelerating the development of a pathbreaking universal drug regimen to end TB.

Chalkidou K, Towse A, Silverman R, Garau M, Ramakrishnan G. Chalkidou K, et al. Among authors: silverman r. BMJ Glob Health. 2020 Apr;5(4):e002061. doi: 10.1136/bmjgh-2019-002061. BMJ Glob Health. 2020. PMID: 32332035 Free PMC article. No abstract available.

9

Modernising vital registration systems: why now?

Oomman N, Mehl G, Berg M, Silverman R. Oomman N, et al. Among authors: silverman r. Lancet. 2013 Apr 20;381(9875):1336-1337. doi: 10.1016/S0140-6736(13)60847-8. Lancet. 2013. PMID: 23602229 No abstract available.

10

How Should the World Pay for a Coronavirus Disease (COVID-19) Vaccine?

Towse A, Chalkidou K, Firth I, Kettler H, Silverman R. Towse A, et al. Among authors: silverman r. Value Health. 2021 May;24(5):625-631. doi: 10.1016/j.jval.2020.12.008. Epub 2021 Feb 19. Value Health. 2021. PMID: 33933230 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

1,299 results

Search Page